Ajax-Loading

Sanofi SA - Capital Expenditures

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Capital-Expenditures" stands at 1.57 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -59.79 percent compared to the value the year prior.
The 1 year change in percent is -59.79.
The 3 year change in percent is -25.45.
The 5 year change in percent is -5.07.
The 10 year change in percent is -43.25.

The Serie's long term average value is 2.05 Billion Euros. It's latest available value, on 09/30/2025, is 23.39 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is +12.52%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -59.79%.

Capital Expenditures for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Capital Expenditures905,699,262,464.00
LogoJohnson & Johnson - Capital Expenditures486,508,953,600.00
LogoAbbVie Inc - Capital Expenditures399,570,305,024.00
LogoRoche Holding AG - Capital Expenditures317,433,206,677.55
LogoAstraZeneca PLC - Capital Expenditures280,205,508,085.11